Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2009;120:785-791
Published online before print August 17, 2009, doi: 10.1161/CIRCULATIONAHA.108.845461
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
120/9/785    most recent
CIRCULATIONAHA.108.845461v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by King, S. M.
Right arrow Articles by Reed, G. L.
PubMed
Right arrow PubMed Citation
Right arrow Articles by King, S. M.
Right arrow Articles by Reed, G. L.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Carotid Artery Disease
Related Collections
Right arrow Animal models of human disease
Right arrow Other arteriosclerosis
Right arrow Genetically altered mice
Right arrow Arterial thrombosis
Right arrow Thrombin
Right arrow Secretion
Right arrow Aggregation
Right arrow Platelets
Right arrow Other Vascular biology
Right arrowRelated Article

(Circulation. 2009;120:785-791.)
© 2009 American Heart Association, Inc.


Vascular Medicine

Platelet Dense-Granule Secretion Plays a Critical Role in Thrombosis and Subsequent Vascular Remodeling in Atherosclerotic Mice

Sarah M. King, PhD; Rachel A. McNamee, BS; Aiilyan K. Houng, BS; Rakesh Patel, MD; Michael Brands, PhD; Guy L. Reed, MS, MD

From Cardiovascular Biology (S.M.K., G.L.R.), Harvard School of Public Health, Boston, Mass; Department of Physiology (M.B.) and Cardiovascular Center (R.A.M., R.P., G.L.R.), Medical College of Georgia, Augusta; and University of Tennessee Health Science Center (A.K.H., G.L.R.), Memphis.

Correspondence to Guy L. Reed, University of Tennessee Health Sciences Center, Coleman D334, 956 Court Ave, Memphis, TN 38163.

Received December 22, 2008; accepted June 15, 2009.

Background— Platelet aggregation plays a critical role in myocardial infarction and stroke; however, the role of platelet secretion in atherosclerotic vascular disease is poorly understood. Therefore, we examined the hypothesis that platelet dense-granule secretion modulates thrombosis, inflammation, and atherosclerotic vascular remodeling after injury.

Methods and Results— Functional deletion of the Hermansky-Pudlak syndrome 3 gene (HPS3–/–) markedly reduces platelet dense-granule secretion. HPS3–/– mice have normal platelet counts, platelet morphology, and {alpha}-granule number, as well as maximal secretion of the {alpha}-granule marker P-selectin; however, their capacity to form platelet-leukocyte aggregates is significantly reduced (P<0.05). To examine the role of platelet dense-granule secretion in these processes, atherosclerosis-prone mice with combined genetic deficiency of apolipoprotein E and HPS3 (ApoE–/–, HPS3–/–) were compared with congenic, atherosclerosis-prone mice with normal platelet secretion (ApoE–/–, HPS3+/+). After 16 to 18 weeks on a high-fat diet, both groups of mice had similar fasting cholesterol levels and body weight. Carotid arteries of ApoE–/–, HPS3+/+ mice thrombosed rapidly after FeCl3 injury, but ApoE–/–, HPS3–/– mice were completely resistant to thrombotic arterial occlusion (P<0.01). Three weeks after injury, neointimal hyperplasia (from {alpha}-smooth muscle actin–positive cells) was significantly less (P<0.001) in arteries from ApoE–/–, HPS3–/– mice. In ApoE–/–, HPS3–/– mice, there were also pronounced reductions in arterial inflammation, as indicated by a 74% decrease in CD45-positive leukocytes (P<0.01) and a 73% decrease in Mac-3–positive macrophages (P<0.05).

Conclusions— In atherosclerotic mice, reduced platelet dense-granule secretion is associated with marked protection against the development of arterial thrombosis, inflammation, and neointimal hyperplasia after vascular injury.


 

CLINICAL PERSPECTIVE


Related Article:

Clinical Summaries
Circulation 2009 120: 717. [Extract] [Full Text]